CTRI Number |
CTRI/2018/05/013918 [Registered on: 16/05/2018] Trial Registered Prospectively |
Last Modified On: |
16/05/2018 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Drug |
Study Design |
Randomized, Parallel Group, Placebo Controlled Trial |
Public Title of Study
|
comparative evaluation of non surgical periodontal therapy in chronic periodontitis with and without administration of curcumin pastilles. |
Scientific Title of Study
|
“To compare the effect of non surgical periodontal therapy in chronic periodontitis with and without administration of curcumin pastilles-A clinico-microbiological study’’. |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Dr Varsha Ranmare |
Designation |
PG student |
Affiliation |
MGVs KBH Dental college,Nashik |
Address |
dept.of periodontology and implantology,M.g.v kbh dental college,nashik
Nashik MAHARASHTRA 422003 India |
Phone |
9403756504 |
Fax |
9403756504 |
Email |
ranmarevarsha@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Drtriveni kale |
Designation |
professor,pg guide |
Affiliation |
MGVs KBH Dental college,Nashik |
Address |
m.g.v k.b.h dental college,nashik
Nashik MAHARASHTRA 422003 India |
Phone |
9403756504 |
Fax |
|
Email |
trivenikale@gmail.com |
|
Details of Contact Person Public Query
|
Name |
Dr Varsha Ranmare |
Designation |
PG student |
Affiliation |
MGVs KBH Dental college,Nashik |
Address |
dept.of periodontology,MGVs KBH dental college,nashik
Nashik MAHARASHTRA 422003 India |
Phone |
9403756504 |
Fax |
9403756504 |
Email |
ranmarevarsha@gmail.com |
|
Source of Monetary or Material Support
|
|
Primary Sponsor
|
Name |
Dr Varsha Ranmare |
Address |
sawali plot no.37,survey no.93,tantradnya nagar,satara parisar,aurangabad |
Type of Sponsor |
Pharmaceutical industry-Indian |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
DrVarsha Ranmare |
MGVs KBH dental college and hospital Nashik |
dept of periodontology and implantology Nashik MAHARASHTRA |
9403756504 9403756504 ranmarevarsha@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Synopsis approval committee |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
chronic periodontitis, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Intervention |
curcumin pastilles |
curcumin patilles which contains turmeric given twice through oral route a day for 3 months
|
Comparator Agent |
not applicable |
not applicable |
|
Inclusion Criteria
|
Age From |
20.00 Year(s) |
Age To |
50.00 Year(s) |
Gender |
Both |
Details |
1)Chronic periodontitis with probing pocket depth ≥6mm
2)Presence of atleast 20 teeth |
|
ExclusionCriteria |
Details |
1)Patients with systemic diseases
2)History of periodontal therapy in the past 6 months
3)Patients on antibiotic use within the past 6 months prior to study
4)Allergy to any test materials
5)Pregnant or lactating females
6)Aggressive periodontitis
7)GradeII and gradeIII mobility |
|
Method of Generating Random Sequence
|
Coin toss, Lottery, toss of dice, shuffling cards etc |
Method of Concealment
|
Not Applicable |
Blinding/Masking
|
Open Label |
Primary Outcome
|
Outcome |
TimePoints |
reduction(4mm)in pocket depth |
parameters checked at baseline after 1 month and after 3 months
|
|
Secondary Outcome
|
Outcome |
TimePoints |
reduction in microbial count after 3 months |
parameters assessed at baseline and after 1 and 3 month |
|
Target Sample Size
|
Total Sample Size="30" Sample Size from India="30"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
N/A |
Date of First Enrollment (India)
|
21/05/2018 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="1" Months="8" Days="30" |
Recruitment Status of Trial (Global)
|
Not Applicable |
Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
|
not yet published |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
Brief Summary
|
abstract:- background:-periodontitis is a infectious disease so the main aim of periodontal therapy is scaling and root planing which is solely not effective so the adjunctive therapy is given such as Medicinal plants have been used as a traditional treatment agent for various human diseases since years.as it is feasible,lesser side effects and ease of availability.so the aim of the study is to compare the the effect of non surgical periodontal therapy in chronic periodontitis with and without administration of curcumin pastilles-A clinico-microbiological study material and methods :-Thirty chronic periodontitis patients with an age range of 20–50 years with probing pocket depth (PPD) of 4–6 mm were included.A)Test group (15 patients):-Full mouth scaling and root planing was done with ultrasonic instrument with administration of curcumin pastilles. B)Control group(15 patients):-Full mouth scaling and root planning with ultrasonic instrument was done.clinical parameters probing pocket depth,clinical attachment level,plaque index,gingival index,gingival recession were recorded at baseline,after 1 minth and after 3 months and CFU was done. results;-there were significant reduction in clinical parameters and microbiologic parameters at baseline,after 1 month and after 3 months in test group as compared to control group. conclusion:-curcumin patilles being an ayurvedic herb is an excellent alternative to other systemic therapeutic agents due to minimal side��’effects. |